Insights: News Releases Kilpatrick Townsend’s Andrew Serafini Appointed to the Board of Directors of Washington Biotechnology & Biomedical Association

SEATTLE (February 2)Kilpatrick Townsend & Stockton announced today that partner Andrew T. Serafini, Ph.D. has been appointed to Washington Biotechnology & Biomedical Association’s (WBBA) Board of Directors.

The WBBA is a trade association serving the life sciences industry in the state of Washington and has 650 member organizations. The WBBA's mission is to "support and help to grow Washington state's life science ecosystem." To learn more about the WBBA, please visit

Dr. Serafini is a registered patent attorney who focuses his practice on strategic and comprehensive intellectual property counseling and management to biotechnology, biopharmaceutical and other life sciences clients. He assists his clients in obtaining, protecting and enforcing their intellectual property rights, especially in the areas of immunology, molecular biology, antibody engineering and therapeutics, vaccines, stem cell technologies, molecular genetics, genomics, proteomics and protein chemistry, pharmaceuticals, medical therapeutics, nanotechnology, clean energy, medical diagnostics and personalized medicine.

Follow the firm on Twitter: @KTS_Law.


Related People

If you would like to receive related insights and information from Kilpatrick Townsend, please provide your contact details by filling out the form and clicking “Agree.” If you would like to access the PDF only, please click “Download Only.”